If Abbott Laboratories Inc. and Alere Inc. can’t come to terms over their troubled $5.8bn merger in the next few months, they’ll be headed to court on Jan. 27.
That’s the latest ruling from Delaware Chancery Court Judge Sam Glasscock, who set the preliminary hearing date in a Sept. 29 order
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?